PTH-112 Association between Helicobacter Pylori Infection and Nonalcoholic Fatty Liver Disease in The United States

Abstract

IntroductionHelicobacter pylori infection has been implicated in the pathogenesis of various gastrointestinal, hematologic, and systemic diseases. Association between Helicobacter pylori infection and nonalcoholic fatty liver disease (NAFLD) is poorly characterised. The aim of this study was to investigate the association between H. pylori positivity with cagA status and NAFLD in the large general population.MethodsThe Third National Health and Nutrition Examination Survey (NHANES) from 1988 to 1994 was utilised in this study. NAFLD was defined by ultrasonographic detection of hepatic steatosis without other known liver diseases. Antibodies to H. pylori and cagA of participants 20 years and older were measured in using ELISA.ResultsAmong total of 5,404 participants who had results of both ultrasonography and H. pylori serology, the prevalence of NAFLD was 31.9%. The prevalence of NAFLD was higher in H. pylori positive subjects (33.5±1.79%) than in negative subjects (26.1±1.65%, p < 0.001). Compared with cagA positive group, participants with negative cagA had higher prevalence of NAFLD (31.1±2.30% vs. 36.4±2.37%, p < 0.001). Overall participants with NAFLD had higher prevalence of H. pylori positivity in multivariable analysis (Odds ratio [OR]: 1.17; 95% confidence interval [CI]: 0.95–1.43) with marginal significance. With regard to presence of cagA protein, H. pylori and cagA positivity was not associated with NAFLD (OR: 1.05; 95% CI: 0.81–1.37) but, cagA negative H. pylori positivity was significantly associated with NAFLD in multivariable analysis (OR: 1.30; 95% CI: 1.01–1.67).ConclusionThe prevalence of NAFLD was higher in H. pylori positive subjects than in negative subjects. Especially, cagA negative H. pylori positivity was significantly associated with NAFLD, independent of other known factors in the general population.References1 Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007;11:1–16, vii.2 Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 2013;57:1357–65.3 Chung GE, Kim D, Kim W, et al. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol 2012;57:150–6.Disclosure of InterestNone Declared

NAFLD, Helicobacter species and the intestinal microbiome

“…Larger studies assessing the role of H. pylori infection on NAFLD have been recently conducted [60][61][62][63][64][65]. For example, Kim et al [63], conducted a study comprising 17,028 South Koreans adults without NAFLD at baseline that included well standardised clinical and laboratory parameters (i.e.…”

Effect of Vitamin D Replacement on Liver Enzymes in Patients with Non-alcoholic Fatty Liver Disease

“…that such a strategy is the most effective and safest approach for controlling NAFLD, more than 50% of people fail to achieve their intended weight loss [4][5][6] .…”

Investigating effect of Helicobacter pylori treatment on improvement of non-alcoholic fatty liver parameters: a randomized trial

“…The incidence of NAFLD complications is rapidly increasing in the world [2,3]; therefore, the economic and clinical burden of this disease is significant. Recently, except for the known risk factors such as obesity, type 2 diabetes, hypertension, and dyslipidemia, the role of the pathogenesis of Helicobacter pylori (HP) is also discussed in the disease and may be associated with NAFLD [4,5].…”